AirHyper Platform

Smart Inhalation Therapy

We focus on nebulizer-based inhalation therapy in critically ill patients and increased efforts towards more personalized therapeutic.
Our platform includes AFDT and DSMT technologies.
The platform will dominate in clinical trials cooperation with pharma.


Adaptive Frequency Delivery Technology

AFDT provides a variety of medicines with optimized aerosol features for more effective delivery to the deep  lungs.

Digital Synchronized Monitor Technology

DSMT collects physiological data to direct drug delivery via an inhaled device based on the patient’s breathing pattern, increasing the efficiency of drug delivery.


Laboratory Tests

Service Process

Why do you need our smart inhaled platform?


Our platform enables you and your doctor to view and track your treatment information. As the results are shared in real-time, you are always connected with your HCPs, who can quickly and easily make an informed adjustment to your respiratory care plan.

Clinicians /Hospital

Collecting high quality data with a centralized platform performs home monitoring for professionals to improve patient course and for lung safety or disease progression clinical trials.

Drugmakers and Pharma

Collaborate with our smart inhaled platform to enhance efficient therapeutics home care with known and novel respiratory drug delivery via our nebulizer (commonly used respiratory medications, COVID specific drugs, biologics).


AeproMED Innovation Corp., Ltd. is dedicated to rooting itself in the biotechnology and medical industry. To continually practice the development direction of”Lean Startup, Cross-Disciplinary Collaborative Thinking, Agile Development” and deepen overall internationalization, AeproMED is committed to implementing an international-perspective, localization, and linking the cooperation between Taiwan’s supply chain industry and international biotechnology institutions. With the unique AFDT and DSMT R&D technology, AeproMED will continue providing customers with the best service and creating more shareholder value.

If you need more, we are here …